Who invested in PolyCore Therapeutics?
PolyCore Therapeutics's investors include National Institutes of Health and Ben Franklin Technology Partners of Southeastern Pennsylvania.
United States · Venture startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
Source recordedSEC filing: $4.7M sold, first sale Feb 2022
PolyCore Therapeutics's investors include National Institutes of Health and Ben Franklin Technology Partners of Southeastern Pennsylvania.
PolyCore Therapeutics has raised 1 round since 2022, none with a disclosed amount.
PolyCore Therapeutics's most recent round was a Venture in Apr 2022.
PolyCore Therapeutics's first round on record, in Apr 2022, was backed by National Institutes of Health and Ben Franklin Technology Partners of Southeastern Pennsylvania.
PolyCore Therapeutics's latest named round is a Venture, in Apr 2022.
PolyCore Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.